Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 145

    1.

    Effects of rosuvastatin and atorvastatin on LDL and HDL particle concentrations in patients with metabolic syndrome: a randomized, double-blind, controlled study.

    Rosenson RS, Otvos JD, Hsia J.

    Diabetes Care. 2009 Jun;32(6):1087-91. Epub 2009 Mar 5.PMID: 19265025 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.

    Strandberg TE, Feely J, Sigurdsson EL; DISCOVERY study group.

    Clin Ther. 2004 Nov;26(11):1821-33.PMID: 15639694 [PubMed - indexed for MEDLINE]Related articles

    3.

    Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.

    Stender S, Schuster H, Barter P, Watkins C, Kallend D; MERCURY I Study Group.

    Diabetes Obes Metab. 2005 Jul;7(4):430-8. Erratum in: Diabetes Obes Metab. 2005 Jul;7(4):460. PMID: 15955130 [PubMed - indexed for MEDLINE]Related articles

    4.

    Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial.

    Schwartz GG, Bolognese MA, Tremblay BP, Caplan R, Hutchinson H, Raza A, Cressman M.

    Am Heart J. 2004 Jul;148(1):e4.PMID: 15215813 [PubMed - indexed for MEDLINE]Related articles

    5.

    Comparison of rosuvastatin versus atorvastatin in South-Asian patients at risk of coronary heart disease (from the IRIS Trial).

    Deedwania PC, Gupta M, Stein M, Ycas J, Gold A; IRIS Study Group.

    Am J Cardiol. 2007 Jun 1;99(11):1538-43. Epub 2007 Apr 16.PMID: 17531577 [PubMed - indexed for MEDLINE]Related articles

    6.

    The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin.

    Fonseca FA, Ruiz A, Cardona-Muñoz EG, Silva JM, Fuenmayor N, Marotti M; DISCOVERY PENTA investigators.

    Curr Med Res Opin. 2005 Aug;21(8):1307-15.PMID: 16083541 [PubMed - indexed for MEDLINE]Related articles

    7.

    Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia.

    Davidson M, Ma P, Stein EA, Gotto AM Jr, Raza A, Chitra R, Hutchinson H.

    Am J Cardiol. 2002 Feb 1;89(3):268-75.PMID: 11809427 [PubMed - indexed for MEDLINE]Related articles

    8.

    Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes -- CORALL study.

    Wolffenbuttel BH, Franken AA, Vincent HH; Dutch Corall Study Group.

    J Intern Med. 2005 Jun;257(6):531-9.PMID: 15910557 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia.

    Olsson AG, Istad H, Luurila O, Ose L, Stender S, Tuomilehto J, Wiklund O, Southworth H, Pears J, Wilpshaar JW; Rosuvastatin Investigators Group.

    Am Heart J. 2002 Dec;144(6):1044-51.PMID: 12486429 [PubMed - indexed for MEDLINE]Related articles

    10.

    Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.

    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.

    Am J Geriatr Pharmacother. 2007 Sep;5(3):185-94.PMID: 17996658 [PubMed - indexed for MEDLINE]Related articles

    11.

    Discovery Belux: comparison of rosuvastatin with atorvastatin in hypercholesterolaemia.

    Herregods MC, Daubresse JC, Michel G, Lamotte M, Vissers E, Vandenhoven G; Discovery Belux.

    Acta Cardiol. 2008 Aug;63(4):493-9.PMID: 18795588 [PubMed - indexed for MEDLINE]Related articles

    12.

    LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study.

    Jukema JW, Liem AH, Dunselman PH, van der Sloot JA, Lok DJ, Zwinderman AH.

    Curr Med Res Opin. 2005 Nov;21(11):1865-74.PMID: 16307708 [PubMed - indexed for MEDLINE]Related articles

    13.

    A comparative study with rosuvastatin in subjects with metabolic syndrome: results of the COMETS study.

    Stalenhoef AF, Ballantyne CM, Sarti C, Murin J, Tonstad S, Rose H, Wilpshaar W.

    Eur Heart J. 2005 Dec;26(24):2664-72. Epub 2005 Sep 5.PMID: 16143705 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effects of rosuvastatin on lipids, lipoproteins and apolipoproteins in the dyslipidaemia of diabetes.

    Betteridge DJ, Gibson JM.

    Diabet Med. 2007 May;24(5):541-9. Epub 2007 Mar 15.PMID: 17367312 [PubMed - indexed for MEDLINE]Related articles

    15.

    Comparison of rosuvastatin versus atorvastatin in patients with heterozygous familial hypercholesterolemia.

    Stein EA, Strutt K, Southworth H, Diggle PJ, Miller E; HeFH Study Group.

    Am J Cardiol. 2003 Dec 1;92(11):1287-93.PMID: 14636905 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.

    Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW; Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.

    Clin Ther. 2004 Sep;26(9):1388-99. Erratum in: Clin Ther. 2005 Jan;27(1):142. PMID: 15531001 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study.

    Schuster H, Barter PJ, Stender S, Cheung RC, Bonnet J, Morrell JM, Watkins C, Kallend D, Raza A; Effective Reductions in Cholesterol Using Rosuvastatin Therapy I study group.

    Am Heart J. 2004 Apr;147(4):705-13.PMID: 15077101 [PubMed - indexed for MEDLINE]Related articles

    18.

    Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.

    Bonnet J, McPherson R, Tedgui A, Simoneau D, Nozza A, Martineau P, Davignon J; CAP Investigators.

    Clin Ther. 2008 Dec;30(12):2298-313.PMID: 19167589 [PubMed - indexed for MEDLINE]Related articles

    19.

    Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial.

    McKenney JM, Jones PH, Adamczyk MA, Cain VA, Bryzinski BS, Blasetto JW; STELLAR Study Group.

    Curr Med Res Opin. 2003;19(8):689-98.PMID: 14687438 [PubMed - indexed for MEDLINE]Related articles

    20.

    Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II.

    Ballantyne CM, Bertolami M, Hernandez Garcia HR, Nul D, Stein EA, Theroux P, Weiss R, Cain VA, Raichlen JS.

    Am Heart J. 2006 May;151(5):975.e1-9.PMID: 16644314 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data